
zzso is an zzso virus untested as a treatment for zzso zzso The zzso zzso zzso conducted a zzso trial of zzso injections of zzso zzso of six patients at each dose level received doses of zzso from zzso zzso units zzso to zzso zzso into a total of 10 sites within the zzso zzso zzso zzso events were identified on physical exams and testing of zzso zzso and liver zzso zzso data were obtained from serial zzso zzso None of the 24 patients experienced serious adverse events related to zzso The maximum tolerated dose was not reached at zzso zzso The median time to progression after treatment with zzso was 46 days zzso 13 to zzso + zzso The median survival time was zzso months zzso zzso to zzso + zzso One patient has not progressed and 1 patient showed zzso of zzso zzso With more than 19 months of zzso zzso recipients at a dose of zzso and zzso at a dose of zzso zzso remain zzso In 2 patients who underwent a second zzso 3 months after zzso injection, a zzso and zzso cell zzso was zzso zzso of zzso into zzso cavities is well tolerated at doses up to zzso zzso 

